2016
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)
Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Research And Treatment 2016, 161: 363-373. PMID: 27866278, PMCID: PMC5226883, DOI: 10.1007/s10549-016-4051-1.Peer-Reviewed Original ResearchConceptsAML/MDSAcute myeloid leukemiaOlder patientsAdjuvant chemotherapyMyeloid leukemiaBreast cancerAnthracycline-based adjuvant chemotherapyMultivariable Cox regressionCooperative group trialsEffect of cyclophosphamideRace/ethnicityAnthracycline usePerformance statusCox regressionMyelodysplastic syndromeClinical trialsGroup trialsOlder womenOncology trialsPatientsStudy registrationOlder ageAnthracyclinesCancerAge
2008
The impact of sharing results of a randomized breast cancer clinical trial with study participants
Partridge AH, Wolff AC, Marcom PK, Kaufman PA, Zhang L, Gelman R, Moore C, Lake D, Fleming GF, Rugo HS, Atkins J, Sampson E, Collyar D, Winer EP. The impact of sharing results of a randomized breast cancer clinical trial with study participants. Breast Cancer Research And Treatment 2008, 115: 123-129. PMID: 18543100, DOI: 10.1007/s10549-008-0057-7.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAnxietyChemotherapy, AdjuvantClinical Trials, Phase III as TopicCommunicationData CollectionHumansMiddle AgedPatient Education as TopicPatient SatisfactionPerceptionRandomized Controlled Trials as TopicRecurrenceRegression AnalysisResearch DesignTrastuzumabConceptsCancer clinical trialsClinical trialsStudy participantsBreast cancer clinical trialsCooperative group trialsSubset of womenResults One hundredClinical trial participantsPercent of participantsRecurrent diseasePatients' perceptionsGroup trialsTrial participantsFavorable responsePsychosocial supportLogistic regressionOne hundredTrialsPatientsTrastuzumabStudy resultsParticipantsTreatmentPreliminary study resultsAnxiety
2006
Study participants’ perceptions of the process and impact of receiving results of N9831
Partridge A, Wolff A, Marcom P, Kaufman P, Moore C, Lake D, Fleming G, Rugo H, Collyar D, Winer E. Study participants’ perceptions of the process and impact of receiving results of N9831. Journal Of Clinical Oncology 2006, 24: 518-518. DOI: 10.1200/jco.2006.24.18_suppl.518.Peer-Reviewed Original ResearchTrial participantsLarge cooperative group trialsPhase III trialsCooperative group trialsSubset of womenClinical trial participantsHealth care providersAdjuvant chemotherapyRecurrent diseaseIII trialsMultivariable analysisClinical trialsBreast cancerGroup trialsCare providersAverage ageFavorable responseClinical investigatorsPsychosocial supportPatientsWomenSubstantial proportionTrialsStudy resultsGreater satisfaction
1990
Improved survival in advanced Hodgkin's disease with the use of combined modality therapy
Brizel D, Winer E, Prosnitz L, Scott J, Crawford J, Moore J, Gockerman J. Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. International Journal Of Radiation Oncology • Biology • Physics 1990, 19: 535-542. PMID: 2211201, DOI: 10.1016/0360-3016(90)90478-3.Peer-Reviewed Original ResearchConceptsSoutheastern Cancer Study GroupAdvanced Hodgkin's diseaseModality therapyTherapy patientsHodgkin's diseaseSoutheastern Cancer Study Group trialTen-year actuarial survivalInduction combination chemotherapyCancer Study GroupActuarial freedomActuarial survivalConsolidation radiotherapyAlone patientsPartial responseCombination chemotherapyInitial diagnosisChemotherapy patientsAcute leukemiaStudy groupGroup trialsChemotherapyPatientsMulti-variate analysisTherapyRelapse